biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > Regardless...

<< Previous

Bullboard Posts

Next >>

Comment by craighenryon Feb 21, 2022 2:40pm

140 Views

Post# 34448235

RE:RE:Regardless...

Finallytherock wrote: I'm not. That's another long who gave up and sold.

Yes, you are right FTR. You andregardless are NOT the same person. I talk to regardless atleast once a week, and he is still holding his BTI position. I have also spoken to you on the phone a few times in the past when you had your BTI position. That last comment shows the pathetic attempt at "knowledge" that has been going on for years........

<< Previous

Bullboard Posts

Next >>

Day trading vs. swing trading strategies for small-cap stocks